Industry News
Telomeres and cancer mortality: The long and the short of it
4/14/2015
Telomeres are short stretches of repeated nucleotides that protect the ends of chromosomes.
Golgi trafficking controlled by G-proteins
4/14/2015
A family of proteins called G proteins are a recognized component of the communication system the human body uses to sense hormones and other chemicals in the bloodstream and to send messages to...
Cancer experts: Too many patients being screened, diagnosed, and treated
4/13/2015
Cancer experts from Memorial Sloan Kettering Cancer Center in New York and Tufts Medical Center in Boston, write that too many people are being screened, diagnosed, and treated for disease because...
Study shows blood cells need nitric oxide to deliver oxygen
4/13/2015
The respiratory cycle is a three-gas and not just a two-gas system of oxygen and carbon dioxide, shows new study that explains the role played by nitric oxide in oxygen delivery.
Inovio Pharmaceuticals, Inc. has announced preliminary data showing that its INO-3112 DNA-based immunotherapy generated strong CD8+ T cell responses in 3 of 4 patients with head and neck cancer...
Genetic screening could improve breast cancer prevention
4/13/2015
A test for a wide range of genetic risk factors could improve doctors' ability to work out which women are at increased risk of developing breast cancer, a major study of more than 65,000 women has...
Epigenomic changes play an important role during the progression of melanoma
4/13/2015
KU Leuven researchers have zeroed in on what makes cancer cells in melanoma so aggressive. They also succeeded in taming the effect in cell cultures.
Nintedanib in lung cancer: Added benefit depends on disease severity
4/13/2015
Advantage in patients without brain metastases, disadvantages in patients with brain metastasesSince November 2014 nintedanib (trade name: Vargatef) has been approved in combination with...
Review highlights potential of cancer immunotherapy plus targeted therapy
4/13/2015
The prospect of combining genomically targeted therapies with drugs that free the immune system to attack cancer suggests "we are finally poised to deliver curative therapies to cancer patients,"...
Breakthrough finds molecules that block previously 'undruggable' protein tied to cancer
4/13/2015
A team of scientists at the University of Kansas has pinpointed six chemical compounds that thwart HuR, an "oncoprotein" that binds to RNA and promotes tumor growth.